http://www.mmm-online.com/obesity/topic/8858/ Articles tagged with Obesity from Medical Marketing and Media MMM mmmsubs@haymarketmedia.com no Studies undercut Medtronic spine treatment benefit, AMA wars over obesity classification, Komen gets a new CEO, GSK offloads thrombosis meds, Lilly gains diabetes treatment, AZN chooses new site http://www.mmm-online.com/business-briefs-medtronic-ama-komen-gsk-lilly-azn/article/299240/ Tue, 18 Jun 2013 16:50:13 GMT Studies undercut Medtronic spine treatment benefit, AMA wars over obesity classification, Komen gets a new CEO, GSK offloads thrombosis meds, Lilly gains diabetes treatment, AZN chooses new site MMM Eisai brings Belivq to 20,000 US pharmacies, along with 200 sales reps and a physician marketing push. http://www.mmm-online.com/weight-loss-category-expands-by-one/article/297241/ Tue, 11 Jun 2013 15:23:45 GMT Eisai brings Belivq to 20,000 US pharmacies, along with 200 sales reps and a physician marketing push. MMM AbbVie's Niaspan pricing gets a hard look; AstraZeneca buys up heart drug and company; Valeant expands eye care portfolio with B&L; Merck halts Parkinson's study; Novo explores liraglutide weight loss results. http://www.mmm-online.com/business-briefs-abbvie-astrazeneca-valeant-merck-novo-nordisk/article/295160/ Tue, 28 May 2013 16:55:44 GMT AbbVie's Niaspan pricing gets a hard look; AstraZeneca buys up heart drug and company; Valeant expands eye care portfolio with B&L; Merck halts Parkinson's study; Novo explores liraglutide weight loss results. MMM Quarterly reports show that that the weight loss category remains a cool one, but studies indicate that even the best marketing plan will have to overcome payer and pricing issues. http://www.mmm-online.com/orexigen-vivus-remain-in-weight-loss-limbo/article/292704/ Thu, 09 May 2013 18:03:25 GMT Quarterly reports show that that the weight loss category remains a cool one, but studies indicate that even the best marketing plan will have to overcome payer and pricing issues. MMM HPV vaccine price cut; Merck files new allergy med with FDA; GSK pursues online transparency; Walgreens ready for greater nurse autonomy; Epocrates ranks high among docs with tablets. http://www.mmm-online.com/business-briefs-merck-gsk-novo-walgreen-epocrates-doximity/article/292622/ Thu, 09 May 2013 14:56:06 GMT HPV vaccine price cut; Merck files new allergy med with FDA; GSK pursues online transparency; Walgreens ready for greater nurse autonomy; Epocrates ranks high among docs with tablets. MMM Arena gets closer to the market place, Takeda scoops up privately held Inviragen, Plan B court decision is coming and Cubist antibotic lands breakthrough therapy status. http://www.mmm-online.com/business-briefs-arena-takeda-teva-cubist/article/292521/ Wed, 08 May 2013 17:05:17 GMT Arena gets closer to the market place, Takeda scoops up privately held Inviragen, Plan B court decision is coming and Cubist antibotic lands breakthrough therapy status. MMM Analysts write expanded Qsymia distribution will do little to boost sales if payers are not on board. http://www.mmm-online.com/analysts-on-qsymia-show-me-the-payers/article/289207/ Wed, 17 Apr 2013 16:02:11 GMT Analysts write expanded Qsymia distribution will do little to boost sales if payers are not on board. MMM When it comes to OTC weight-loss products, deceptive advertising produces diminishing returns, a study has found. http://www.mmm-online.com/hyperbolic-otc-obesity-drug-ads-backfire/article/285193/ Wed, 20 Mar 2013 16:22:49 GMT When it comes to OTC weight-loss products, deceptive advertising produces diminishing returns, a study has found. MMM Researchers find weaknesses in HRT-breast cancer studies, Novo announces GLP-1 weight loss results http://www.mmm-online.com/business-briefs-hrt-hpv-novo-nordisk/article/284834/ Mon, 18 Mar 2013 16:02:14 GMT Researchers find weaknesses in HRT-breast cancer studies, Novo announces GLP-1 weight loss results MMM The drug maker is promoting the no-fee, all-access app to healthcare professionals as part of its Qsymia pitch. http://www.mmm-online.com/vivus-launches-qsymia-weight-loss-app/article/284171/ Wed, 13 Mar 2013 14:59:48 GMT The drug maker is promoting the no-fee, all-access app to healthcare professionals as part of its Qsymia pitch. MMM